Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 17 04:00PM ET
16.50
Dollar change
+0.03
Percentage change
0.18
%
IndexRUT P/E13.67 EPS (ttm)1.21 Insider Own6.32% Shs Outstand57.33M Perf Week7.14%
Market Cap952.05M Forward P/E7.28 EPS next Y2.27 Insider Trans0.00% Shs Float54.06M Perf Month16.20%
Income69.70M PEG- EPS next Q0.36 Inst Own92.55% Short Float3.41% Perf Quarter31.26%
Sales1.12B P/S0.85 EPS this Y-20.19% Inst Trans-2.10% Short Ratio4.44 Perf Half Y23.87%
Book/sh-13.24 P/B- EPS next Y-4.98% ROA5.53% Short Interest1.84M Perf Year1.29%
Cash/sh4.88 P/C3.38 EPS next 5Y- ROE- 52W Range9.93 - 19.79 Perf YTD-12.84%
Dividend Est.0.59 (3.57%) P/FCF69.49 EPS past 5Y- ROI8.00% 52W High-16.62% Beta0.96
Dividend TTM0.60 (3.64%) Quick Ratio1.61 Sales past 5Y0.35% Gross Margin66.12% 52W Low66.25% ATR (14)0.75
Dividend Ex-DateAug 27, 2024 Current Ratio2.11 EPS Y/Y TTM46.88% Oper. Margin23.13% RSI (14)64.27 Volatility4.05% 4.94%
Employees2200 Debt/Eq- Sales Y/Y TTM0.48% Profit Margin6.23% Recom3.29 Target Price15.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-3.75% Payout49.22% Rel Volume0.87 Prev Close16.47
Sales Surprise1.89% EPS Surprise59.48% Sales Q/Q-4.75% EarningsAug 09 BMO Avg Volume414.99K Price16.50
SMA208.91% SMA5012.63% SMA20014.25% Trades Volume360,279 Change0.18%
Date Action Analyst Rating Change Price Target Change
Oct-20-23Initiated Wolfe Research Peer Perform
Jan-06-23Downgrade Morgan Stanley Equal-Weight → Underweight $28
Sep-08-22Initiated BTIG Research Neutral
Aug-01-22Initiated Morgan Stanley Equal-Weight $33
Jun-21-22Initiated BofA Securities Underperform $25
Sep-03-24 07:55AM
06:30AM
Aug-22-24 05:00PM
Aug-12-24 09:35AM
09:30AM
08:18AM Loading…
Aug-10-24 08:18AM
Aug-09-24 10:52AM
07:40AM
06:30AM
06:00AM
Aug-02-24 10:00AM
Jul-31-24 09:47AM
Jul-29-24 08:05AM
Jul-24-24 04:21AM
Jul-22-24 07:42AM
05:00PM Loading…
Jul-18-24 05:00PM
Jun-25-24 07:47AM
Jun-24-24 06:30AM
Jun-20-24 07:30AM
May-21-24 04:30PM
May-13-24 11:52AM
May-10-24 02:12PM
May-09-24 10:54AM
06:30AM
06:00AM
May-01-24 05:00PM
Apr-23-24 05:00PM
Mar-06-24 06:00AM
Feb-10-24 08:55AM
Feb-09-24 10:07PM
11:43AM Loading…
11:43AM
07:45AM
07:07AM
06:30AM
06:00AM
Feb-07-24 05:00PM
Jan-24-24 05:00PM
Jan-21-24 08:33AM
Jan-09-24 06:00AM
Dec-14-23 05:00PM
Dec-01-23 06:00AM
05:13AM
Nov-29-23 05:00PM
Nov-22-23 09:34AM
Nov-21-23 07:23AM
07:15AM
07:13AM
05:30AM
05:00AM
Nov-14-23 10:00AM
Oct-31-23 06:50AM
Oct-25-23 05:00PM
Sep-28-23 08:10PM
Sep-06-23 05:00PM
Aug-11-23 06:08AM
Aug-08-23 10:19PM
06:30AM
06:00AM
Jul-11-23 05:00PM
Jun-30-23 06:15AM
Jun-21-23 08:00PM
May-20-23 08:26AM
May-15-23 05:38PM
05:00PM
09:30AM
09:30AM
May-13-23 08:16AM
12:05AM
May-12-23 06:30AM
06:15AM
06:00AM
May-01-23 01:08PM
Apr-26-23 08:00PM
Apr-22-23 07:20AM
Apr-21-23 06:15PM
Apr-20-23 05:00PM
Mar-26-23 08:45AM
Mar-22-23 06:46AM
Mar-10-23 10:32AM
Feb-24-23 10:00AM
05:50AM
Feb-22-23 05:00PM
Feb-16-23 07:28AM
Feb-15-23 04:53PM
05:32AM
Feb-14-23 06:54PM
12:08PM
06:30AM
06:00AM
Feb-08-23 05:00PM
Jan-30-23 01:25PM
Jan-25-23 07:00AM
Jan-24-23 05:00PM
Jan-21-23 06:16PM
Dec-20-22 11:34AM
10:29AM
06:30AM
06:00AM
Dec-14-22 05:00PM
Nov-08-22 10:03AM
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Melcher David FDirectorFeb 12 '24Buy16.252,00032,50045,080Feb 12 07:08 PM